< Back to latest news & events

AGRITECH + IP

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

October 2025

  • Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it?

This case centres on the evidence required to establish “serious doubts” regarding novelty of the well-known Cripps Pink (“Pink Lady”) and Cripps Red (“Sundowner”) apple varieties. As a reminder, novelty of a plant variety right is assessed using a test of “commercial novelty”, rather than a test of “absolute novelty” as used in patent law.

The EU General Court decision (T-159/24) reaffirms that implicit consent to commercialise a plant variety can undermine its EU plant variety right (CPVR) protection.  The Court decided that the supply of varieties to nurseries without clear restrictions as regards their use long before filing the CPVR applications was enough to provide implicit consent to exploit them commercially, to the detriment of their EU plant variety rights.

The takeaway? Even if the intention is merely to hand out new varieties for testing purposes in commercially relevant field trials, it is best to expressly limit the use of new varieties for testing or research purposes to preserve their novelty in a subsequent CPVR application.

The Court also addressed the role of declarations as evidence. It confirmed that declarations may carry weight even without supporting documentation, provided they’re credible, made by impartial parties, and consistent with other evidence.

In short, record-keeping and express limitations regarding commercial uses in contracts are key. Creators of new varieties should document when varieties are disposed of and retain evidence of any use restrictions placed on those varieties to mitigate the possibility of a third party establishing “serious doubts” regarding the novelty of the variety.

Click the button below to read our full article.

Latest updates

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Zombie Fashion Brands

Episode 4 Zombie Fashion Brands  

Read article

HGF Director Promotions

We are pleased to announce a number of director promotions that will take effect from 1st December 2025. These individuals have demonstrated exceptional expertise, commitment, and leadership within their respective …

Read article

Mycelium Meets Market Reality: The Quiet Role of IP in Scaling Sustainable Materials

Fungal materials are increasingly used in applications ranging from sustainable packaging and leather alternatives to construction composites, textiles, and biotechnology. These developments are transforming fungi from a niche research subject …

Read article
Event - 24th - 25th November 2025

HGF Partners with 3AF for the P2I2025 Symposium

HGF are pleased to be a partner of P2I2025, the annual symposium organised by the Intellectual Property Commission of the French Aeronautics and Astronautics Association (3AF). The event brings together …

Event details